NICOLE PASAO-PHAM: Open Payments
NPI 1447549068 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 5 payments from 5 companies in 2025. Trend: 2023 $339 · 2024 $183 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Intrinsic Therapeutics | 1 | $214 |
| UCB, Inc. | 1 | $23 |
| Bioventus LLC | 1 | $22 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Medinc of Texas | 1 | $20 |
Products named: BARRICAID ACD (ANNULAR CLOSURE DEVICE), Rystiggo, BONESCALPEL & SONICONE (O.R.), Exparel.
Industry payments across TX — which companies pay providers there.
